Kam Lawrence
Follow13F filer, CIK 1802765, HONOLULU, HI
Kam Lawrence reported $0 across 1 holding for the quarter ended 2019-12-31, in a 13F-HR/A filed 2020-09-17.
Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0001567619-20-016823
- Period
- 2019-12-31
- Reported value
- $0
- Holdings
- 1
- Top 10 weight
- New
- Sold out
Stakes and trades reported after 2019-12-31
13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.
- FENC FENNEC PHARMACEUTICALS INC: 13G/A 1,592,559 shares, 4.5% of the class, 13G/A filed 2026-11-16, 0001013594-26-001189Timeline
Accepted , ingested
Holdings, Q4 2019
Share positions as resolved from 13F-HR/A 0001567619-20-016823, largest first. % of portfolio is the value over $0, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| 00 | 0 | $0 | Value filed as zero, left out of ratios.Amount filed as zero, left out of ratios. |
How Q4 2019 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001567619-20-003219 | superseded | 2020-02-13 | acceptance time not in the bulk data set | ||
| 13F-HR/A 0001567619-20-016823 | base | restatement | 2020-09-17 | acceptance time not in the bulk data set |